Transimmune

About:

Transimmune is a pioneering dendritic cell therapy business that has discovered how dendritic cells are produced biologically.

Website: https://transimmune.com

Top Investors: Bill & Melinda Gates Foundation

Description:

Transimmune is a provider of dendritic cell therapy, having discovered the physiological process by which dendritic cells are produced.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Düsseldorf, Nordrhein-Westfalen, Germany

Founded Date:

2012-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-09-20

IPO Status:

Private

Industries: